116202 ⎘
Hydrolases acting on ester bonds (3.1); Carboxylic ester hydrolases (3.1.1) Lipoprotein lipase (3.1.1.34)
COMPOSITIONS AND METHODS FOR ENZYME IMMOBILIZATION
#2CHO CELL-DERIVED PROTEIN SECRETORY FACTORS AND EXPRESSION VECTORS COMPRISING THE SAME
#3Method for Synthesizing Diglyceride
#4RECOMBINANTLY ENGINEERED, LIPASE/ESTERASE-DEFICIENT MAMMALIAN CELL LINES
#5B CELLS FOR IN VIVO DELIVERY OF THERAPEUTIC AGENTS AND DOSAGES THEREOF
#6LPL-GPIHBP1 FUSION POLYPEPTIDES
#7Compositions and methods for enzyme immobilization
#8REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS
#9Polynucleotides encoding lipoprotein lipase for the treatment of hyperlipidemia
#10SYSTEMS AND METHODS FOR CHARACTERIZATION OF HYPERTRIGLYCERIDEMIA
#11Reduction of lipase activity in product formulations
#12LPL/RLP FOR ASSESSMENT OF CARDIOVASCULAR DISEASE RISK
#13LIPOPROTEIN LIPASE FOR TREATMENT OF HYPERTRIGLYCERIDEMIC-RELATED CONDITIONS INCLUDING ACUTE PANCREATITIS
#14Reduction of lipase activity in product formulations
#15Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitis
#16LPL variant therapeutics
#17Netrin loop peptide mimetics and uses thereof
#18Enzymatic Pretreatment For Making Dried Fruits
#19Methods For Treating Clinical Conditions Associated With Lipoprotein Lipase Activity
#20LPL VARIANT THERAPEUTICS
#21TREATMENT OF NON-ALCOHOLIC STEATOTIC HEPATITIS (NASH)
#22Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
#23Treatment of Non-Alcoholic Steatotic Hepatitis (Nash)
#24Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
#25Lipoprotein lipase and lipoprotein lipase activators in the treatment of inflammatory conditions